Wed, January 14, 2009
Tue, January 13, 2009
Mon, January 12, 2009
Sun, January 11, 2009
Fri, January 9, 2009
Thu, January 8, 2009
Wed, January 7, 2009
Tue, January 6, 2009
Mon, January 5, 2009
[ Mon, Jan 05th 2009 ] - Market Wire
Avexa and Progen Merger Update
Fri, January 2, 2009
Thu, January 1, 2009
Wed, December 31, 2008
[ Wed, Dec 31st 2008 ] - Market Wire
Obesity Comes With a Price Tag
Tue, December 30, 2008
Mon, December 29, 2008
Wed, December 24, 2008
Tue, December 23, 2008

AMAG Pharmaceuticals, Inc. to Present at the 27th Annual J.P. Morgan Healthcare Conference


//health-fitness.news-articles.net/content/2009/ .. 7th-annual-j-p-morgan-healthcare-conference.html
Published in Health and Fitness on Wednesday, January 7th 2009 at 14:08 GMT, Last Modified on 2009-01-07 14:09:11 by Market Wire   Print publication without navigation


LEXINGTON, Mass.--([ BUSINESS WIRE ])--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that Brian J.G. Pereira, MD, President and Chief Executive Officer, will present an overview of the Company at the 27th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2009 at 9:30 a.m. PT. The conference is being held in San Francisco, CA, January 12-15, 2009.

A live audio webcast of the presentation and breakout session will be accessible through the Investors section of the Company's website at [ www.amagpharma.com ]. Following the conference, the webcast will be archived on the AMAG Pharmaceuticals, Inc. website until February 10, 2009.

About AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company that utilizes its proprietary technology for the development and commercialization of a therapeutic iron compound to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease.

Ferumoxytol is being developed for use as an intravenous iron replacement therapeutic agent for the treatment of iron deficiency anemia and as a diagnostic agent for vascular-enhanced magnetic resonance imaging to assess peripheral arterial disease.


Publication Contributing Sources